FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2025/08/092709 [Registered on: 08/08/2025] Trial Registered Prospectively
Last Modified On: 08/08/2025
Post Graduate Thesis  Yes 
Type of Trial  Interventional 
Type of Study   Surgical/Anesthesia 
Study Design  Single Arm Study 
Public Title of Study   Comparative Study of various Reconstruction Procedures following surgery of For Carcinoma Tongue with respect to post operative Speech And Swallowing assessment  
Scientific Title of Study   Assessment Of Speech And Swallowing In Post-Operative Cases For Carcinoma Tongue Following Reconstruction Procedures 
Trial Acronym  NIL 
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Dr Anuja Kulkarni 
Designation  Sr DMO SG Consultant 
Affiliation  JRH Mumbai 
Address  Room no 5 Department of ENT, Jagjivan Ram Railway Hospital, Maratha Mandir Marg ,Mumbai Central , Mumbai
Room no 5 Department of ENT, Jagjivan Ram Railway Hospital, Maratha Mandir Marg ,Mumbai Central , Mumbai Ram Railway Hospital, Maratha Mandir Marg ,Mumbai Central , Mumbai
Mumbai
MAHARASHTRA
400008
India 
Phone  9819464115  
Fax    
Email  dr.anujakulkarni@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  Dr Nisma Loknath 
Designation  PG Tainee 
Affiliation  JRH Mumbai 
Address  Jagjivan Ram Railway Hospital, Maratha Mandir Marg ,Mumbai Central , Mumbai
Jagjivan Ram Railway Hospital, Maratha Mandir Marg ,Mumbai Central , Mumbai
Mumbai
MAHARASHTRA
400008
India 
Phone  9819464115  
Fax    
Email  pbsjrh@gmail.com  
 
Details of Contact Person
Public Query
 
Name  Dr Anuja Kulkarni 
Designation  Sr DMO SG Consultant 
Affiliation  JRH Mumbai 
Address  Room No 5, Department of ENT Jagjivan Ram Railway Hospital, Maratha Mandir Marg ,Mumbai Central , Mumbai India
Room No 5, Department of ENT Jagjivan Ram Railway Hospital, Maratha Mandir Marg ,Mumbai Central , Mumbai India
Mumbai
MAHARASHTRA
400008
India 
Phone  9819464115  
Fax    
Email  dr.anujakulkarni@gmail.com  
 
Source of Monetary or Material Support  
Not applicable 
 
Primary Sponsor  
Name  Jagjivan Ram Railway Hospital  
Address  Jagjivan Ram Railway Hospital Maratha Mandir Marg Mumbai Central Mumbai 400008  
Type of Sponsor  Other [Govt Hospital] 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Dr A S Kulkarni  Jagjivan Ram Railway Hospital  Room No 5 Jagjivan Ram Railway HospitalMaratha mandir marg Mumbai Central Mumbai 400008
Mumbai
MAHARASHTRA 
9819464115

dr.anujakulkarni@gmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
IEC/JRH  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition: C029||Malignant neoplasm of tongue, unspecified,  
 
Intervention / Comparator Agent  
Type  Name  Details 
Intervention  primary closure  Post operative sppech and swallowing  
Comparator Agent  Flap closure  Post operative speech and swallowing  
 
Inclusion Criteria  
Age From  18.00 Year(s)
Age To  99.00 Year(s)
Gender  Both 
Details  diagnosed with tongue cancer requiring surgical treatment 
 
ExclusionCriteria 
Details  Children less than18 years old
Pregnant women
Unconscious patients, mentally challenged patients
 
 
Method of Generating Random Sequence   Not Applicable 
Method of Concealment   Not Applicable 
Blinding/Masking   Not Applicable 
Primary Outcome  
Outcome  TimePoints 
Locoregional control of disease   AT 3months 6 months and at 2 years follow up  
 
Secondary Outcome  
Outcome  TimePoints 
Disease specific mortality  at 3 months 6 months 1 year 
 
Target Sample Size   Total Sample Size="39"
Sample Size from India="39" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   N/A 
Date of First Enrollment (India)   22/08/2025 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="2"
Months="3"
Days="15" 
Recruitment Status of Trial (Global)   Not Applicable 
Recruitment Status of Trial (India)  Not Yet Recruiting 
Publication Details   N/A 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - NO
Brief Summary  

The tongue cancer has posed the challenge to clinicians with respect to preservation of form and function post cancer surgery and So far there is no consensus with regards to the best possible reconstruction amongst the various options available , with regards to preservation of form and function i.e speech and swallowing which adds to quality of life  in case of tongue cancer.

 In order to attempt to answer this question, this observational  study is being undertaken pertaining to the prevailing practices in our cohort.

 
Close